Nektar Therapeutics (NKTR) Stock Price, Quote, News & History | Benzinga

Nektar Therapeutics (NKTR) Stock Price, Quote, News & History

NKTRNASDAQ

Trade with Public

Trade with Public

$73.21

0.450.62%

Last update: Aug 5, 9:21 AM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$73.56

Close

-

Volume / Avg.

229.20K / 993.29K

Day Range

$72.20 - $74.23

52 Wk Range

21.60 - 109.00

Market Cap

$2.47B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

22.27%

Days to Cover

6.97

Recent Nektar Therapeutics News

Nektar Therapeutics, Compass Pathways, Sila Realty Trust And Other Big Stocks Moving Higher On Monday

Nektar Therapeutics (NASDAQ: NKTR) rose on positive results for alopecia treatment. Other top gainers include AVEX, CMPS, ATAI, GHRS, POET, SILA, BLD, INV, MXL, KSPI.

Avi Kapoor

Why Are Nektar Shares Up Monday?

Nektar Therapeutics shares are trading higher Monday after a blinded 16-week treatment extension results in Phase 2b REZOLVE-AA study.

Dylan Berman

Why Is Nektar Therapeutics Stock Gaining Wednesday?

Nektar Therapeutics stock surged after positive data showed sustained and deepening disease control with its eczema therapy.

Vandana Singh

Nektar Therapeutics Stock Is Trending Tuesday: What's Going On?

Shares of Nektar Therapeutics (NASDAQ: NKTR) are soaring Tuesday following a significant update regarding the company's atopic dermatitis treatment.

Alex Perry

Datadog, Spotify, Marriott, Ferrari And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-203.76M

Investing Cash Flow (TTM)

-395.68M

Financing Cash Flow (TTM)

710.11M

Free Cash Flow (TTM)

-203.94M

Capital Expenditure (TTM)

-187.00K

Net Change in Cash (TTM)

110.68M

Analyst Trends and Forecast

3

Feb

2

1

Mar

3

1

Apr

1

1

May

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.97B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

25.54

PB Ratio (TTM)

4.26

Earnings Yield % (TTM)

-10.90%

Earnings Yield % (FWD)

-11.25%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$17.05

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$149.58M

Debt to Equity

0.14

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$73.56

Close

-

Volume / Avg.

229.20K / 993.29K

Day Range

$72.20 - $74.23

52 Wk Range

21.60 - 109.00

Market Cap

$2.47B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

22.27%

Days to Cover

6.97

About

Sector

Health Care

Industry

Pharmaceuticals

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company dir...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Nektar Therapeutics (NKTR) stock?

A

You can purchase shares of Nektar Therapeutics (NASDAQ:NKTR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Nektar Therapeutics (NKTR) competitors?

A

There are no as such competitors for Nektar Therapeutics.

Q

What is the forecast, or price target, for Nektar Therapeutics (NKTR) stock?

A

Nektar Therapeutics has a consensus price target of $111.45.

Q

What is the current price for Nektar Therapeutics (NKTR)?

A

The stock price for Nektar Therapeutics (NASDAQ: NKTR) is $73.21 last updated August 5, 2026 at 9:21 AM EDT.

Q

Does Nektar Therapeutics (NKTR) pay a dividend?

A

There are no upcoming dividends for Nektar Therapeutics.

Q

When is Nektar Therapeutics (NASDAQ:NKTR) reporting earnings?

A

Nektar Therapeutics does not have any upcoming earnings scheduled.

Q

Is Nektar Therapeutics (NKTR) going to split?

A

There is no upcoming split for Nektar Therapeutics.

Q

What sector and industry does Nektar Therapeutics (NKTR) operate in?

A

Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.